15:00 17.02.2021
Interfax-Ukraine to host press conference National Certification Commission of Experts of Aesthetic Medicine Approves National Protocols on Main Complications in Cosmetology 1 min read
On Wednesday, February 17, at 15.00, the press center of the Interfax-Ukraine news agency will host a press conference entitled National Certification Commission of Experts of Aesthetic Medicine Approves National Protocols on Main Complications in Cosmetology , these protocols will be created for the first time in the history of Ukraine and will help doctors in the prevention and treatment of complications in aesthetic medicine. Participants include President of the Certification Commission, Doctor Inha Andrashko; Member of the International Scientific Committee for Safety IMCAS Alert, Doctor Ihor Rudenko; Co-author for developing of IMCAS Alert, Head of the ReFuture clinic, Developer of the Age Managent method, Doctor Yevhen Shahov; Founder and Head
К сведению: о пресс-конференции в пресс-центре агентства Интерфакс-Украина на тему Национальная сертификационная комиссия экспертов эстетической медицины утверждает Национальные протоколы по основным осложнениям в косметологии
interfax.com.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from interfax.com.ua Daily Mail and Mail on Sunday newspapers.
До відома: про прес-конференцію в прес-центрі агентства Інтерфакс-Україна на тему Національна сертифікаційна комісія експертів естетичної медицини затверджує Національні протоколи щодо основних ускладнень у косметології
interfax.com.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from interfax.com.ua Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board
February 8, 2021 GMT
Regulatory News:
NOXXON Pharma N.V.
(Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the appointment of four leading pancreatic cancer experts to its Scientific Advisory Board (SAB). Led by the newly appointed Chair, Dr. Jose Saro, the SAB will provide strategic and scientific counsel to NOXXON’s clinical programs in this indication.
“These prominent research leaders bring long-standing clinical expertise, cutting-edge scientific knowledge, and a track record of successfully developing new drugs to treat this devastating disease. They fully understand the challenges of developing new drugs for pancreas cancer where the tumor microenvironment plays a large role in resisting ant